(Q60230370)
Statements
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application (English)
0 references
4 April 2014
0 references
5
0 references
8
0 references
2925-2932
0 references
article by Robert Trondl et al published 4 April 2014 in Chemical Science